
### [NCIT:C3055](http://purl.obolibrary.org/obo/NCIT_C3055)
**Label:** Giant Cell Tumor

**Subclasses:** [NCIT:C121893](http://purl.obolibrary.org/obo/NCIT_C121893) (Giant Cell Lesion of Small Bones), [NCIT:C4304](http://purl.obolibrary.org/obo/NCIT_C4304) (Malignancy in Giant Cell Tumor of Bone), [NCIT:C27477](http://purl.obolibrary.org/obo/NCIT_C27477) (Benign Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C3402](http://purl.obolibrary.org/obo/NCIT_C3402) (Tenosynovial Giant Cell Tumor), [NCIT:C6535](http://purl.obolibrary.org/obo/NCIT_C6535) (Malignant Tenosynovial Giant Cell Tumor), [NCIT:C49107](http://purl.obolibrary.org/obo/NCIT_C49107) (Giant Cell Tumor of Soft Tissue), [NCIT:C121933](http://purl.obolibrary.org/obo/NCIT_C121933) (Malignant Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C6532](http://purl.obolibrary.org/obo/NCIT_C6532) (Tenosynovial Giant Cell Tumor, Localized Type), [NCIT:C121932](http://purl.obolibrary.org/obo/NCIT_C121932) (Giant Cell Tumor of Bone), [NCIT:C121931](http://purl.obolibrary.org/obo/NCIT_C121931) (Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C3738](http://purl.obolibrary.org/obo/NCIT_C3738) (Osteoclastic Giant Cell-Rich Tumor of Bone), 

**Class expressions from DL-Learner:**

- Thing 54.88%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 39.98%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 36.74%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 36.74%


